20-23603622-T-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001008693.3(CST9):ā€‹c.368A>Gā€‹(p.Asn123Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000169 in 1,614,216 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00019 ( 0 hom., cov: 33)
Exomes š‘“: 0.00017 ( 1 hom. )

Consequence

CST9
NM_001008693.3 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.506
Variant links:
Genes affected
CST9 (HGNC:13261): (cystatin 9) The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the kininogens. The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions, where they appear to provide protective functions. The cystatin locus on chromosome 20 contains the majority of the type 2 cystatin genes and pseudogenes. This gene is located in the cystatin locus and encodes a secreted protein that may play a role in hematopoietic differentiation or inflammation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.030639768).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CST9NM_001008693.3 linkuse as main transcriptc.368A>G p.Asn123Ser missense_variant 2/2 ENST00000376971.4 NP_001008693.2 Q5W186

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CST9ENST00000376971.4 linkuse as main transcriptc.368A>G p.Asn123Ser missense_variant 2/21 NM_001008693.3 ENSP00000366170.4 Q5W186

Frequencies

GnomAD3 genomes
AF:
0.000191
AC:
29
AN:
152204
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000247
AC:
62
AN:
251490
Hom.:
1
AF XY:
0.000169
AC XY:
23
AN XY:
135916
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000665
Gnomad ASJ exome
AF:
0.000694
Gnomad EAS exome
AF:
0.000163
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000149
Gnomad OTH exome
AF:
0.000977
GnomAD4 exome
AF:
0.000166
AC:
243
AN:
1461894
Hom.:
1
Cov.:
35
AF XY:
0.000161
AC XY:
117
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000693
Gnomad4 ASJ exome
AF:
0.00115
Gnomad4 EAS exome
AF:
0.00123
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.000131
Gnomad4 NFE exome
AF:
0.0000962
Gnomad4 OTH exome
AF:
0.000248
GnomAD4 genome
AF:
0.000190
AC:
29
AN:
152322
Hom.:
0
Cov.:
33
AF XY:
0.000134
AC XY:
10
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.0000722
Gnomad4 AMR
AF:
0.000784
Gnomad4 ASJ
AF:
0.000864
Gnomad4 EAS
AF:
0.000772
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000882
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000209
Hom.:
0
Bravo
AF:
0.000227
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000264
AC:
32
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 25, 2023The c.368A>G (p.N123S) alteration is located in exon 2 (coding exon 2) of the CST9 gene. This alteration results from a A to G substitution at nucleotide position 368, causing the asparagine (N) at amino acid position 123 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.011
T
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.65
FATHMM_MKL
Benign
0.025
N
LIST_S2
Benign
0.48
T
M_CAP
Benign
0.0016
T
MetaRNN
Benign
0.031
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.1
M
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.031
Sift
Uncertain
0.016
D
Sift4G
Uncertain
0.050
T
Polyphen
1.0
D
Vest4
0.096
MVP
0.19
MPC
0.27
ClinPred
0.024
T
GERP RS
0.73
Varity_R
0.17
gMVP
0.093

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199726022; hg19: chr20-23584259; API